Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the NA+/I- symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3430-3435

  Kitazono, Masaki ^a   Robey, Rob ^a   Zhan, Zhirong ^a   Sarlis, Nicholas J ^b   Skarulis, Monica C ^b   Aikou, Takashi ^c   Bates, Susan ^a   Fojo, Tito ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEPSIPEPTIDE; FR 901228; HISTONE DEACETYLASE INHIBITOR; IODINE 125; RADIOACTIVE IODINE; THYROGLOBULIN;

ACETYLATION; ADJUVANT THERAPY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; ION TRANSPORT; PRIORITY JOURNAL; THYROID CARCINOMA; TREATMENT FAILURE;

ACETYLATION; ADENOCARCINOMA, FOLLICULAR; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CARCINOMA; CARRIER PROTEINS; DEPSIPEPTIDES; ENZYME INHIBITORS; GENE EXPRESSION; HISTONE DEACETYLASES; HISTONES; HUMANS; IODINE RADIOISOTOPES; MEMBRANE PROTEINS; PEPTIDES, CYCLIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYMPORTERS; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034913856     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3430     Document Type: Article

References (26)

1. Thyroid cancer: A lethal endocrine neoplasm
2. Thyroid tumors
3. Papillary and follicular thyroid carcinoma
4. Current trends in the management of well differentiated papillary thyroid carcinoma
5. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer
6. Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer
7. Anaplastic carcinoma of the thyroid
8. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
9. Anaplastic transformation of metastatic follicular carcinoma of the thyroid
10. Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases
11. Immunohistology of anaplastic thyroid carcinoma. A study of 43 cases
12. Surgical treatment of distant metastases in differentiated thyroid cancer: Indication and results
13. External radiotherapy in thyroid cancers
14. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
15. Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: A Southeastern Cancer Study Group Trial
16. Antineoplastic activity of taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo
17. Treatment of anaplastic giant and spindle cell carcinoma of the thyroid gland with combination Adriamycin and radiation therapy. A new approach
18. Effects of retinoids and role of retinoic acid receptors in human thyroid carcinomas and cell lines derived therefrom
19. Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results
20. Isotretinoin in metastatic thyroid cancer
21. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells
22. Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines
23. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression
24. Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen
25. Antibodies specific to acetylated histones document the existence of deposition- and transcription-related histone acetylation in Tetrahymena
26. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: Basic aspects